Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02291978

MR Guided High Intensity Focused Ultrasound for Lumbar Back Pain

A Feasibility Study to Evaluate the Safety and Initial Effectiveness of MR Guided High Intensity Focused Ultrasound (MRgHIFU) in the Treatment of Facetogenic Lumbar Back Pain

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this protocol is to assess the ExAblate 2100 MR guided high intensity focused ultrasound device as an intervention for treatment of facetogenic lower back pain.

Detailed description

This is a single group, single arm, open/nonblinded, non-randomized study. The primary outcomes are safety and preliminary efficacy. The InSightec ExAblate 2100 MRgHIFU system is a non-invasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone.The study will reach primary completion 12 months from the time the study opens to accrual.

Conditions

Interventions

TypeNameDescription
DEVICEExAblate 2100The InSightec ExAblate 2100 MRgHIFU system is a non-invasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone.

Timeline

Start date
2014-10-01
Primary completion
2020-02-20
Completion
2020-02-20
First posted
2014-11-17
Last updated
2020-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02291978. Inclusion in this directory is not an endorsement.